|
Valoración de DCF de Biomx Inc. (PHGE)
IL | Healthcare | Biotechnology | AMEX
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
BiomX Inc. (PHGE) Bundle
¡Evalúe las perspectivas financieras de Biomx Inc. (PHGE) con la experiencia! Esta calculadora DCF (PHGE) proporciona datos financieros previamente llenos y ofrece flexibilidad total para modificar el crecimiento de los ingresos, WACC, los márgenes y otros supuestos críticos para alinearse con sus proyecciones.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | -.1 | -.4 | -.4 | -.6 | -.7 | -.9 | -1.1 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 166.42 | 25 | 25 | 25 | 25 | 25 |
| EBITDA | -20.2 | -27.9 | -32.9 | -23.7 | -22.8 | -.4 | -.6 | -.7 | -.9 | -1.1 |
| EBITDA, % | 100 | 100 | 100 | 17649.25 | 6390.76 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .3 | 2.2 | 2.6 | 2.5 | .9 | -.1 | -.1 | -.1 | -.2 | -.2 |
| Depreciation, % | 100 | 100 | 100 | -1880.6 | -243.98 | 20 | 20 | 20 | 20 | 20 |
| EBIT | -20.5 | -30.1 | -35.5 | -26.2 | -23.7 | -.4 | -.6 | -.7 | -.9 | -1.1 |
| EBIT, % | 100 | 100 | 100 | 19529.85 | 6634.73 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 82.3 | 56.3 | 62.1 | 33.3 | 15.9 | -.1 | -.1 | -.1 | -.2 | -.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .2 | .0 | -.1 | .6 | .6 | -.1 | -.1 | -.1 | -.2 | -.2 |
| Account Receivables, % | 100 | 100 | 100 | -423.13 | -160.78 | 20 | 20 | 20 | 20 | 20 |
| Inventories | 2.0 | .0 | .1 | .4 | .0 | -.2 | -.2 | -.3 | -.3 | -.4 |
| Inventories, % | 100 | 100 | 100 | -294.78 | 0 | 40 | 40 | 40 | 40 | 40 |
| Accounts Payable | 3.3 | 2.3 | 2.8 | .8 | 1.4 | -.1 | -.1 | -.1 | -.2 | -.2 |
| Accounts Payable, % | 100 | 100 | 100 | -611.94 | -386.83 | 20 | 20 | 20 | 20 | 20 |
| Capital Expenditure | -1.3 | -1.0 | -3.7 | -.1 | -.1 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 83.58 | 14.01 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 | -0.08796757 |
| EBITAT | -18.9 | -29.9 | -35.5 | -26.2 | -23.7 | -.4 | -.5 | -.7 | -.9 | -1.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -18.8 | -27.4 | -36.2 | -26.8 | -21.9 | -1.2 | -.6 | -.8 | -1.0 | -1.2 |
| WACC, % | 13.85 | 14.8 | 14.87 | 14.87 | 14.87 | 14.65 | 14.65 | 14.65 | 14.65 | 14.65 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -3.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -1 | |||||||||
| Terminal Value | -10 | |||||||||
| Present Terminal Value | -5 | |||||||||
| Enterprise Value | -8 | |||||||||
| Net Debt | -1 | |||||||||
| Equity Value | -7 | |||||||||
| Diluted Shares Outstanding, MM | 5 | |||||||||
| Equity Value Per Share | -1.42 |
What You Will Receive
- Comprehensive Financial Model: BiomX Inc.'s (PHGE) actual data provides an accurate DCF valuation.
- Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential drivers.
- Real-Time Calculations: Automatic updates allow you to see results immediately as you adjust inputs.
- Professional-Grade Template: A polished Excel file crafted for expert-level valuation.
- Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.
Key Features
- 🔍 Real-Life PHGE Financials: Pre-filled historical and projected data for BiomX Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate BiomX’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize BiomX’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file for BiomX Inc. (PHGE).
- Step 2: Review BiomX's pre-filled financial data and projections.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model refresh in real-time as you modify assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose BiomX Inc. (PHGE) Calculator?
- Designed for Experts: A sophisticated tool utilized by biopharma analysts, researchers, and investment professionals.
- Comprehensive Data: BiomX's historical and projected financials integrated for precision.
- Flexible Scenario Analysis: Effortlessly model various forecasts and assumptions.
- Insightful Outputs: Instantly computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout.
Who Should Use BiomX Inc. (PHGE)?
- Biotechnology Students: Explore cutting-edge research and gain practical experience with real-world applications.
- Researchers: Utilize advanced models and data in your studies surrounding microbiome therapies.
- Investors: Evaluate your investment strategies and analyze the potential of BiomX Inc. (PHGE) within the biotech sector.
- Industry Analysts: Enhance your analysis with a customizable model tailored for biotech companies.
- Healthcare Entrepreneurs: Understand how innovative companies like BiomX Inc. (PHGE) are transforming the healthcare landscape.
What the Template Contains
- Pre-Filled DCF Model: BiomX Inc.’s (PHGE) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate BiomX Inc.’s (PHGE) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.